The Structure and Functions of PRMT5 in Human Diseases

被引:44
|
作者
Motolani, Aishat [1 ]
Martin, Matthew [1 ]
Sun, Mengyao [1 ]
Lu, Tao [1 ,2 ,3 ,4 ]
机构
[1] Indiana Univ Sch Med, Dept Pharmacol & Toxicol, Indianapolis, IN 46202 USA
[2] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA
[3] Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA
[4] Indiana Univ Sch Med, Indiana Univ, Melvin & Bren Simon Comprehens Canc Ctr, Indianapolis, IN 46202 USA
来源
LIFE-BASEL | 2021年 / 11卷 / 10期
关键词
PRMT5; cancer; cardiovascular disease; neurodegenerative diseases; diabetes; inflammation; PROTEIN ARGININE-METHYLTRANSFERASE; GENE-EXPRESSION; METHYLATION; PHOSPHORYLATION; TARGET; CELLS; DIMETHYLATION; INHIBITION; COMPLEXES; MAINTAIN;
D O I
10.3390/life11101074
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Since the discovery of protein arginine methyltransferase 5 (PRMT5) and the resolution of its structure, an increasing number of papers have investigated and delineated the structural and functional role of PRMT5 in diseased conditions. PRMT5 is a type II arginine methyltransferase that catalyzes symmetric dimethylation marks on histones and non-histone proteins. From gene regulation to human development, PRMT5 is involved in many vital biological functions in humans. The role of PRMT5 in various cancers is particularly well-documented, and investigations into the development of better PRMT5 inhibitors to promote tumor regression are ongoing. Notably, emerging studies have demonstrated the pathological contribution of PRMT5 in the progression of inflammatory diseases, such as diabetes, cardiovascular diseases, and neurodegenerative disorders. However, more research in this direction is needed. Herein, we critically review the position of PRMT5 in current literature, including its structure, mechanism of action, regulation, physiological and pathological relevance, and therapeutic strategies.</p>
引用
收藏
页数:16
相关论文
共 50 条
  • [1] Acetylation regulates the oncogenic functions of PRMT5
    Vo, Tam Thuy Lu
    Do, Yen Thi
    Pham, Thi Tuyet Mai
    Shin, So-Jin
    Kim, Jin Young
    Lee, Seungmee
    Ha, Eunyoung
    Seo, Ji Hae
    CANCER RESEARCH, 2023, 83 (07)
  • [2] Crystal structure of the human PRMT5:MEP50 complex
    Antonysamy, Stephen
    Bonday, Zahid
    Campbell, Robert M.
    Doyle, Brandon
    Druzina, Zhanna
    Gheyi, Tarun
    Han, Bomie
    Jungheim, Louis N.
    Qian, Yuewei
    Rauch, Charles
    Russell, Marijane
    Sauder, J. Michael
    Wasserman, Stephen R.
    Weichert, Kenneth
    Willard, Francis S.
    Zhang, Aiping
    Emtage, Spencer
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2012, 109 (44) : 17960 - 17965
  • [3] A new move for PRMT5
    Joanna E. Huddleston
    Nature Reviews Molecular Cell Biology, 2011, 12 : 76 - 76
  • [4] The Where and the How of PRMT5
    Cheryl M. Koh
    Marco Bezzi
    Ernesto Guccione
    Current Molecular Biology Reports, 2015, 1 (1) : 19 - 28
  • [5] Cryo-electron microscopy structure of a human PRMT5:MEP50 complex
    Timm, David E.
    Bowman, Valorie
    Madsen, Russell
    Rauch, Charles
    PLOS ONE, 2018, 13 (03):
  • [6] PRMT5 function and targeting in cancer
    Kim, Hyungsoo
    Ronai, Ze'ev A.
    CELL STRESS, 2020, 4 (08) : 199 - 215
  • [7] PRMT5 restricts ERK activity
    Katharine H. Wrighton
    Nature Reviews Molecular Cell Biology, 2011, 12 : 689 - 689
  • [8] PRMT5 promotes retinoblastoma development
    Jiang, Yu
    Zheng, Guangying
    Sun, Xiantao
    HUMAN CELL, 2023, 36 (01) : 329 - 341
  • [9] PRMT5: splicing up tolerance
    Kumar, Rathan
    Ranganathan, Parvathi
    JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (20):
  • [10] DEVELOPMENT A new move for PRMT5
    Huddleston, Joanna E.
    NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2011, 12 (02) : 76 - 76